A Study in People With Abnormal Fat Levels in the Blood

• Status: Completed
• Trial end date: 2006-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purposes of this study are to determine:

• The safety of the study medication and any side effects that might be associated with it;

• Whether the study medication can help patients with low levels of 'good' cholesterol (HDL-C) and high blood fats or triglycerides (TG);

• How much of the study medication should be given to patients;

• How the study medication compares to fenofibrate (Lofibra), a drug used for people with low levels of HDL-C and high levels of TG.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company

Criteria

Inclusion Criteria:

• Men and women between 18 and 80 years of age

• People with abnormal fat levels in the blood (low HDL, high TG)

Exclusion Criteria:

• People with diabetes

• People whose blood pressure is greater than 160/95 mm Hg, on or off blood pressure medicine

• People who have had frequent chest pain or unstable angina, a heart attack or a heart procedure, including stent placement, within the past 3 months